ISPE Highlights
iSpeak Blog
Is Process Development Really GMP?
iSpeak Blog
Human‑in‑the‑Loop as an Illusion of Control?
Pharmaceutical Engineering Magazine
Guidance Documents
Highlights From ISPE Knowledge Network
Explore webinars, training PE articles, and more relevant to your job function.
These top focus areas bring the most relevant ISPE content to the forefront of your browsing experience. Explore webinars, training, PE articles and more.
Facilities & Equipment
- Inside Hepalink’s 2026 ISPE Facility of the Year Awards (FOYA) Innovation – Novel Technology Category Award-Winning Project: Shenzhen Hepalink Pingshan New Pre-filled Syringe Manufacturing Facility
- Beyond Defect Detection: Transforming Vision AI into Process Intelligence in Pharma Manufacturing
- Commissioning and Qualification Microlearning: Periodic Review
- Commissioning and Qualification Microlearning: Process Control and Automation
Information Systems
- Beyond Defect Detection: Transforming Vision AI into Process Intelligence in Pharma Manufacturing
- Digital Foundations for Pharma 4.0™: Key Insights from the 2026 ISPE Pharma 4.0™ and Biopharma Conference
- Human‑in‑the‑Loop as an Illusion of Control?
- Digital Delivery in Action: Rethinking Risk During Life Sciences Facility Expansions
Management
- Women in Pharma® at the 2026 ISPE Annual Meeting and Expo: Leadership, Continuous Improvement, AI, and Networking Opportunities
- How the ISPE Academy Quality Management Maturity (QMM) Certificate Program Was Designed and Why Quality Culture Matters More Than Ever
- Digital Foundations for Pharma 4.0™: Key Insights from the 2026 ISPE Pharma 4.0™ and Biopharma Conference
- Accelerate Sustainable Pharmaceutical Manufacturing with Exclusive On-Demand Learning Through ISPE Membership
Product Development
- Is Process Development Really GMP?
- Inside Chugai Pharma Manufacturing’s 2026 ISPE Facility of the Year Awards (FOYA) Project: FJ3
- From Breakthrough to Bedside: Turning Scientific Innovation into Therapies Patients Can Access
- Spray-Drying Technology Transfer of Amorphous Solid Dispersions
Quality
- Women in Pharma® at the 2026 ISPE Annual Meeting and Expo: Leadership, Continuous Improvement, AI, and Networking Opportunities
- How the ISPE Academy Quality Management Maturity (QMM) Certificate Program Was Designed and Why Quality Culture Matters More Than Ever
- Commissioning and Qualification Microlearning: Periodic Review
- Commissioning and Qualification Microlearning: Process Control and Automation
Regulatory
- From Documentation to Architecture: Applying AI Assisted Validation within ASTM E2500 and EU GMP Annex 1
- Rethinking Product Lifecycle (PLC) Logic Before Rethinking Capital: A Case for Controls-First Optimization
- US Food and Drug Administration (US FDA) on Artificial Intelligence (AI), Critical Thinking, and the Enduring Principles of Quality
- From Component to Patient: Keeping Pharmaceutical Supply Continuous Through Regulatory Transitions
Supply Chain
- 2026 Facility of the Year Awards (FOYA) Category Winner for Supply Chain - BSP Pharmaceuticals
- Inside BSP Pharmaceuticals’ 2026 ISPE Facility of the Year Awards (FOYA) Supply Chain Category Award-Winning Project
- From Component to Patient: Keeping Pharmaceutical Supply Continuous Through Regulatory Transitions
- Autonomous Batch Disposition: Transforming Pharmaceutical Manufacturing with Rules, Risk, and AI Signals
Facilities & Equipment
Information Systems
Management
Product Development
Quality
Regulatory
Supply Chain
- Inside Hepalink’s 2026 ISPE Facility of the Year Awards (FOYA) Innovation – Novel Technology Category Award-Winning Project: Shenzhen Hepalink Pingshan New Pre-filled Syringe Manufacturing Facility
- Beyond Defect Detection: Transforming Vision AI into Process Intelligence in Pharma Manufacturing
- Commissioning and Qualification Microlearning: Periodic Review
- Commissioning and Qualification Microlearning: Process Control and Automation
- Beyond Defect Detection: Transforming Vision AI into Process Intelligence in Pharma Manufacturing
- Digital Foundations for Pharma 4.0™: Key Insights from the 2026 ISPE Pharma 4.0™ and Biopharma Conference
- Human‑in‑the‑Loop as an Illusion of Control?
- Digital Delivery in Action: Rethinking Risk During Life Sciences Facility Expansions
- Women in Pharma® at the 2026 ISPE Annual Meeting and Expo: Leadership, Continuous Improvement, AI, and Networking Opportunities
- How the ISPE Academy Quality Management Maturity (QMM) Certificate Program Was Designed and Why Quality Culture Matters More Than Ever
- Digital Foundations for Pharma 4.0™: Key Insights from the 2026 ISPE Pharma 4.0™ and Biopharma Conference
- Accelerate Sustainable Pharmaceutical Manufacturing with Exclusive On-Demand Learning Through ISPE Membership
- Is Process Development Really GMP?
- Inside Chugai Pharma Manufacturing’s 2026 ISPE Facility of the Year Awards (FOYA) Project: FJ3
- From Breakthrough to Bedside: Turning Scientific Innovation into Therapies Patients Can Access
- Spray-Drying Technology Transfer of Amorphous Solid Dispersions
- Women in Pharma® at the 2026 ISPE Annual Meeting and Expo: Leadership, Continuous Improvement, AI, and Networking Opportunities
- How the ISPE Academy Quality Management Maturity (QMM) Certificate Program Was Designed and Why Quality Culture Matters More Than Ever
- Commissioning and Qualification Microlearning: Periodic Review
- Commissioning and Qualification Microlearning: Process Control and Automation
- From Documentation to Architecture: Applying AI Assisted Validation within ASTM E2500 and EU GMP Annex 1
- Rethinking Product Lifecycle (PLC) Logic Before Rethinking Capital: A Case for Controls-First Optimization
- US Food and Drug Administration (US FDA) on Artificial Intelligence (AI), Critical Thinking, and the Enduring Principles of Quality
- From Component to Patient: Keeping Pharmaceutical Supply Continuous Through Regulatory Transitions
- 2026 Facility of the Year Awards (FOYA) Category Winner for Supply Chain - BSP Pharmaceuticals
- Inside BSP Pharmaceuticals’ 2026 ISPE Facility of the Year Awards (FOYA) Supply Chain Category Award-Winning Project
- From Component to Patient: Keeping Pharmaceutical Supply Continuous Through Regulatory Transitions
- Autonomous Batch Disposition: Transforming Pharmaceutical Manufacturing with Rules, Risk, and AI Signals
Access Your Member Benefits
Collaborate on a global scale, drive innovation, lead conversations, and more.
Become a member of ISPE.
Explore the benefits of ISPE membership.
Explore the benefits of ISPE membership.
Increased Access to Good Practice Guides Access to Good Practice Guidance Documents
With an ISPE membership, you’ll gain access to 24+ Good Practice Guides.
Get Involved
Enhance your ISPE Membership through involvement at the local and international level. Through knowledge sharing, networking, and engaging thought leadership, you can contribute to shaping the future of the pharmaceutical industry.
ISPE Membership
ISPE is the most dynamic community in the industry, with a global network of 25,000+ professionals spanning the complete pharmaceutical lifecycle. With resources available for all stages of your career, an ISPE Membership is a career game changer.
ISPE in the News
Latest
-
From Component to Patient: Keeping Pharmaceutical Supply Continuous Through Regulatory Transitions
-
One Mission, Two Strengths: Why the ISPE Conference in Berlin Brings Pharma 4.0™ and Biopharma Together
-
Countdown to the 2026 ISPE Annual Meeting & Expo
-
US Government Appoints CBER, CDER Directors
-
CMOs Invest In US Manufacturing, Partnerships
-
How AI Supports Computer System Validation
-
AES Adds FM 4882 Certification To Cleanroom Panel System
-
DuChemBio To Build Radiopharmaceutical Plant In S. Korea
-
Risk Management A Pillar Of Pharma Manufacturing Excellence
- AI Supports Skilled Validation Experts
Community Discussions
Community Discussions
Mar 18, 2026
Data Integrity
Mar 12, 2026
Mar 11, 2026
Data Integrity
Mar 11, 2026
Advanced Therapy Medicinal Products
Biotechnology
Videos
Latest Magazine Issue
This issue explores how digital transformation is reshaping regulated industries, highlighting advancements in modular digital ecosystems and AI to accelerate decision velocity while redefining validation frameworks.
Corporate Partners
View Corporate Partners
